Healthcare & Medical Devices Global On demand · 24-48h

Global Veterinary Sutures Market Strategic Research Report

Global Veterinary Sutures Market Strategic Research Report
$3,500 USD
Market Research Reports
Strategic Research Report
Global Veterinary Sutures Market
$1.55B2025
7.6%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Absorbable Sutures, Non-absorbable Sutures

By Application: Companion Animals, Livestock Animals, Exotic Animals

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: B. Braun, Johnson & Johnson, Medtronic, Betatech Medical, Changzhou Zener Medtec, Gamastech, Génia, KATSAN Medical Devices, CP Medical, Vetersut, Vitrex Medical, AIP Medical, GPC Medical, AdvaCare Pharma, Cortis

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 120 pages
Market size 2025
$1.55B
Billion USD
Forecast CAGR
7.6%
2025-2032
Forecast 2032
$2.6B
Projected
Области
5
Asia Pacific · Latin America · MEA · Europe · North America

Обзор

Scope of the Report

The global Veterinary Sutures market size is predicted to grow from US$ 1,547 million in 2025 to US$ 2,586 million in 2032; it is expected to grow at a CAGR of 7.6% from 2026 to 2032.

Veterinary sutures are sterile medical devices used to close surgical incisions or wounds in animals during veterinary procedures, including soft tissue surgery, orthopedic operations, and emergency trauma care. These products are available in absorbable and non-absorbable forms and are manufactured using materials such as polyglycolic acid, polydioxanone, nylon, polypropylene, and silk. In 2025, the global consumption of veterinary sutures is estimated at approximately 10.0 thousand tons, with an average selling price of around US$158,000 per ton. The industry maintains a gross margin of 62%–78%, supported by stable procedural demand, standardized veterinary procurement systems, and gradual shifts toward higher-performance synthetic suture materials.

Industry analysis suggests that veterinary sutures are gradually shifting from basic consumables toward differentiated surgical materials. Competitive positioning increasingly depends on absorbability profiles, tensile strength stability, knot security, and compatibility with minimally invasive veterinary procedures rather than price competition alone.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Veterinary Sutures market?

What factors are driving Veterinary Sutures market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Veterinary Sutures market opportunities vary by end market size?

How does Veterinary Sutures break out by Type, by Application?

This report presents a comprehensive overview of the global Veterinary Sutures market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Absorbable Sutures
  • Non-absorbable Sutures

Segment by Material Type

  • Synthetic Polymer Sutures
  • Natural Material Sutures

Segment by Filament Structure

  • Monofilament Sutures
  • Multifilament Sutures

Segment by Application

  • Companion Animals
  • Livestock Animals
  • Exotic Animals

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Veterinary Sutures market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Companion Animals, Livestock Animals, Exotic Animals evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Veterinary Sutures Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 7.6%
Regional growth momentum
Market share by segment
Key metrics
Base value
$1.55B
2025
Forecast
$2.6B
2032
CAGR
7.6%
2025–2032
Области
5
global
Key companies
B. BraunJohnson & JohnsonMedtronicBetatech MedicalChangzhou Zener MedtecGamastechGéniaKATSAN Medical Devices
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Absorbable SuturesNon-absorbable Sutures
By Application
Companion AnimalsLivestock AnimalsExotic Animals

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Absorbable Sutures
  • 3.1.3 Non-absorbable Sutures
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Companion Animals
  • 4.1.3 Livestock Animals
  • 4.1.4 Exotic Animals
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 B. Braun
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Johnson & Johnson
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Medtronic
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Betatech Medical
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Changzhou Zener Medtec
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Gamastech
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Génia
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 KATSAN Medical Devices
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 CP Medical
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Vetersut
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Vitrex Medical
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 AIP Medical
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 GPC Medical
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 AdvaCare Pharma
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Cortis
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

How big is the global Veterinary Sutures market?
The global Veterinary Sutures market is estimated at US$ 1.55 billion in 2025 (base year) and is projected to reach US$ 2.59 billion by 2032.
How fast is the Veterinary Sutures market expected to grow?
The market is expected to grow at a CAGR of 7.6% from 2026 to 2032, expanding from US$ 1.55 billion in 2025 to US$ 2.59 billion in 2032, roughly 1.7 times its base-year value.
What does the Veterinary Sutures market cover?
Veterinary sutures are sterile medical devices used to close surgical incisions or wounds in animals during veterinary procedures, including soft tissue surgery, orthopedic operations, and emergency trauma care. These products are available in absorbable and non-absorbable forms and are manufactured using materials such as polyglycolic acid, polydioxanone, nylon, polypropylene, and silk. In 2025, the global consumption of veterinary sutures is estimated at approximately 10.0 thousand tons, with an average selling price of around US$158,000 per ton.
How is the Veterinary Sutures market segmented by type?
By type, the market is segmented into Absorbable Sutures and Non-absorbable Sutures.
What are the key applications of Veterinary Sutures?
Key applications covered include Companion Animals, Livestock Animals and Exotic Animals.
Which companies are profiled in the Veterinary Sutures market report?
Key players profiled include B. Braun, Johnson & Johnson, Medtronic, Betatech Medical, Changzhou Zener Medtec, Gamastech, Génia and KATSAN Medical Devices, among 15 companies covered in total.
What geographies does the Veterinary Sutures market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Veterinary Sutures?
What factors are driving Veterinary Sutures market growth, globally and by region?
Who should buy the Veterinary Sutures market report?
The report is intended for manufacturers and solution providers, distributors and end users in Companion Animals, Livestock Animals and Exotic Animals, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Veterinary Sutures market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from 3 500,00 $
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.